GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Peter Lynch Fair Value

Star Lake Bioscience Co (SHSE:600866) Peter Lynch Fair Value : ¥13.65 (As of May. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Star Lake Bioscience Co's PEG is 1. Star Lake Bioscience Co's 5-Year TTM EBITDA Growth Rate is 25. Star Lake Bioscience Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.55. Therefore, the Peter Lynch Fair Value for today is ¥13.65.

As of today (2024-05-01), Star Lake Bioscience Co's share price is ¥5.66. Star Lake Bioscience Co's Peter Lynch fair value is ¥13.65. Therefore, Star Lake Bioscience Co's Price to Peter Lynch Fair Value Ratio for today is 0.41.


The historical rank and industry rank for Star Lake Bioscience Co's Peter Lynch Fair Value or its related term are showing as below:

SHSE:600866' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.32   Med: 0.36   Max: 0.42
Current: 0.41


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Star Lake Bioscience Co was 0.42. The lowest was 0.32. And the median was 0.36.


SHSE:600866's Price-to-Peter-Lynch-Fair-Value is ranked better than
96.51% of 86 companies
in the Biotechnology industry
Industry Median: 1.6 vs SHSE:600866: 0.41

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Star Lake Bioscience Co Peter Lynch Fair Value Historical Data

The historical data trend for Star Lake Bioscience Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Peter Lynch Fair Value Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 11.63

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 11.63 13.65

Competitive Comparison of Star Lake Bioscience Co's Peter Lynch Fair Value

For the Biotechnology subindustry, Star Lake Bioscience Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Price-to-Peter-Lynch-Fair-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Price-to-Peter-Lynch-Fair-Value falls into.



Star Lake Bioscience Co Peter Lynch Fair Value Calculation

Star Lake Bioscience Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 25 *0.546
=13.65

Star Lake Bioscience Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.55.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Star Lake Bioscience Co  (SHSE:600866) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.

Star Lake Bioscience Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=5.66/13.65
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Lake Bioscience Co Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines